XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Current Assets    
Cash and cash equivalents $ 294 $ 563
Funds deposited by counterparties 31 33
Restricted cash 11 17
Accounts receivable, net 1,049 1,024
Inventory 370 412
Derivative instruments 850 764
Cash collateral paid in support of energy risk management activities 163 287
Prepayments and other current assets 277 302
Current assets - held-for-sale 0 1
Current assets - discontinued operations 0 197
Total current assets 3,045 3,600
Property, plant and equipment, net 2,610 3,048
Other Assets    
Equity investments in affiliates 383 412
Operating lease right-of-use assets, net 499  
Goodwill 573 573
Intangible assets, net 561 591
Nuclear decommissioning trust fund 748 663
Derivative instruments 426 317
Deferred income taxes 55 46
Other non-current assets 271 289
Non-current assets - held-for-sale 0 77
Non-current assets - discontinued operations 0 1,012
Total other assets 3,516 3,980
Total Assets 9,171 10,628
Current Liabilities    
Current portion of long-term debt and capital leases 87 72
Current portion of operating lease liabilities 74  
Accounts payable 723 863
Derivative instruments 778 673
Cash collateral received in support of energy risk management activities 31 33
Accrued expenses and other current liabilities 601 680
Current liabilities - held-for-sale 0 5
Current liabilities - discontinued operations 0 72
Total current liabilities 2,294 2,398
Other Liabilities    
Long-term debt and capital leases 5,794 6,449
Non-current operating lease liabilities 513  
Nuclear decommissioning reserve 290 282
Nuclear decommissioning trust liability 448 371
Derivative instruments 374 304
Deferred income taxes 71 65
Other non-current liabilities 1,016 1,274
Non-current liabilities - held-for-sale 0 65
Non-current liabilities - discontinued operations 0 635
Total other liabilities 8,506 9,445
Total Liabilities 10,800 11,843
Redeemable noncontrolling interest in subsidiaries 19 19
Commitments and Contingencies
Stockholders' Equity    
Common stock; $0.01 par value; 500,000,000 shares authorized; 421,830,474 and 420,288,886 shares issued and 258,570,598 and 283,650,039 shares outstanding at June 30, 2019 and December 31, 2018, respectively 4 4
Additional paid-in-capital 8,488 8,510
Accumulated deficit (5,355) (6,022)
Less treasury stock, at cost - 163,259,876 and 136,638,847 shares at June 30, 2019 and December 31, 2018, respectively (4,686) (3,632)
Accumulated other comprehensive loss (99) (94)
Total Stockholders' Equity (1,648) (1,234)
Total Liabilities and Stockholders' Equity $ 9,171 $ 10,628